ISTH 2022 Congress
Fibrinolysis and Proteolysis
Theme Navigation
-
Abstract Number: VPB0636
A Comparative Study Of Intravenous Bolus Versus Bolus With Continuous Infusion Of Tranexamic Acid To Reduce Blood Loss In Major Surgical Procedures
-
Abstract Number: OC 76.2
A zebrafish model of dysfibrinogenemia caused by hotspot mutations in the human fibrinogen gamma chain
-
Abstract Number: PB0632
Activity of some protease inhibitors in patients with arterial hypertension of high risk.
-
Abstract Number: VPB0633
Adipokines and insulin resistance in young individuals with various metabolic phenotypes
-
Abstract Number: PB0641
Alternative cleavage method of LPXTG motif in group A streptococcus by LPXTGase-like protein has a higher selectivity towards aromatic fourth position residues at the sortase A consensus sequence
-
Abstract Number: VPB0635
Attenuation of Thrombotic Biomarkers in a Hyperlipidaemic Sprague Dawley Rats Model
-
Abstract Number: OC 29.1
Both α- and γ-chain crosslinks mediated by FXIIIa affect fibrin fibre resistance to rupture
-
Abstract Number: OC 46.5
Carbamylation in acute ischemic stroke thrombi impairs t-PA-mediated thrombolysis and increases thrombus frailty
-
Abstract Number: PB0619
Clot Collapse in Scanning Electron Microscopy (SEM)
-
Abstract Number: OC 76.5
Clot Destabilisation by the Inclusion of Fibrin with Truncations in the αC-region
-
Abstract Number: OC 76.4
CM-352 reduces rivaroxaban-associated ICH by mechanisms dependent on MMP-10 and fibrinolysis inhibition
-
Abstract Number: VPB0648
Combination Thrombolytic Therapy Using Electrohydraulic Radial and Focused Shock Waves in The Animal Model of Embolic Common Carotid Artery Occlusion
-
Abstract Number: VPB0637
Comparison between Intermittent Bolus versus Continuous Intravenous Infusion of Tranexamic Acid in Hematological Disorders with Thrombocytopenia (BRAVE Trial)
-
Abstract Number: PB0624
Comparison of fibrinogen concentrates to cryoprecipitate in restoring clot integrity and stability against fibrinolytic degradation
-
Abstract Number: PB0643
COVID-19-associated hemostasis alterations and outcomes in acute ischemic stroke patients treated with intravenous thrombolysis
-
Abstract Number: PB0622
Determining the dominant-negative causality of FXIII heterozygous mutations using a bi-cistronic, bi-tagged expression system
-
Abstract Number: OC 29.4
Development of recombinant antibodies targeting the coagulation factor XIII-B subunit for research and therapeutic use
-
Abstract Number: VPB0647
DNase 1 unveils the presence and unlocks the thrombolytic potential of intraveneously administered t-PA in large vessel occlusion acute ischemic stroke